{"record_key":"generian-pharmaceuticals-inc","identifier":"generian-pharmaceuticals-inc","external_key":"B06809","title":"Generian Pharmaceuticals, Inc","summary":null,"url":"https://inventions.pitt.edu/startups/generian-pharmaceuticals-inc","json_url":"https://inventions.pitt.edu/startups/generian-pharmaceuticals-inc.json","object_key":"startups","description":"Generian Pharmaceuticals is developing oral small-molecule medicines for targets often addressed by biologic drugs. Co-founded by University of Pittsburgh researchers Toren Finkel, Bill Chen and Yuan Liu, the company combines expertise in protein regulation and drug discovery to pursue new treatment options. [1]: https://www.generian.com/about/\nIts preclinical pipeline includes inhibitors of FcRn, a protein that helps maintain circulating antibodies, for potential use in antibody-mediated autoimmune disease. Generian is also exploring novel therapeutic targets through a research collaboration with Astellas, expanding its search for medicines that can be taken by mouth. [2]: https://www.generian.com/pipeline/","attributes":[{"key":"website","label":"Website","values":["https://www.generian.com/"]},{"key":"sector","label":"Sector","values":["Therapeutics"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Immunology"]},{"key":"funding_stage","label":"Funding Stage","values":["Series A+"]},{"key":"founders","label":"Founders","values":["Toren Finkel","Bill Chen","Yuan Liu"]}],"related":[]}